Podcast: Play in new window | Download (Duration: 12:21 — 11.3MB) | Embed

Subscribe: Spotify | iHeartRadio | Blubrry | Email | TuneIn | Deezer | RSS | More

Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview with Quoc-Dien Trinh, MD, assistant professor of surgery at Harvard Medical School  and co-director of the Dana-Farber/Brigham and Women’s Prostate Cancer Center.  On this podcast he discusses the gap in prostate cancer survival of African American men compared to Caucasian men. His data shows that the biological differences in tumor aggressiveness among African American men may have been exaggerated, and the gap in survival is more likely to be the result of racial inequity and lack of access to quality care.

At the May 10 Prostate Cancer Symposium his session is “Racial Variations in Prostate Cancer Care: Differences or disparities.” Go here for more information and to register.

Podcast: Play in new window | Download (Duration: 6:01 — 5.5MB) | Embed

Subscribe: Spotify | iHeartRadio | Blubrry | Email | TuneIn | Deezer | RSS | More

Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview with Glenn Bubley, MD, director of the Division of Genitourinary Medical Oncology at the Beth Israel Medical Center  and associate professor of medicine at Harvard Medical School. He is the 2009 recipient of the Jack Colbert Memorial Award.

On this podcast he discusses the good news about new treatments for metastatic and non-metastatic prostate cancer. Important clinical trials have been performed that have shown that earlier treatment of metastatic disease with combinations of existing agents have provided a major improvement in overall and cancer specific survival. This includes combinations of hormonal agents like Lupron with Abiraterone or Lupron with the chemotherapeutic agent Docetaxel.

At the May 10 Prostate Cancer Symposium his session is “Newer Therapeutic Strategies for Advanced Prostate Cancer.” Go here for more information and to register.